NCT06660901View on ClinicalTrials.gov

Cannabinoid Hyperemesis Syndrome. Prospective Multicenter Study of Patients Admitted to Adult Emergency Departments in Maine-et-Loire.

RecruitingOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

July 25, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
D000096704Cannabinoid Hyperemesis Syndrome
Trial Locations (3)

49100

RECRUITING

Angers Centre Hospitalier Universitaire (CHU), Angers

49300

RECRUITING

Centre Hospitalier de Cholet, Cholet

49400

RECRUITING

Centre Hospitalier de Saumur, Saumur

All Listed Sponsors
lead

University Hospital, Angers

OTHER_GOV

NCT06660901 - Cannabinoid Hyperemesis Syndrome. Prospective Multicenter Study of Patients Admitted to Adult Emergency Departments in Maine-et-Loire. | Biotech Hunter | Biotech Hunter